Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.

With some forms of cancer, race matters. New research may explain why Hispanic children are more prone to a type of blood cancer.

One of the challenges of leukemia is that it likes to return.  Once the blood cancer comes back, it’s more difficult to treat and beat. Medical scientists are experimenting with a way to boost the body’s immune system to get in on the fight and win.

Staying on top of a chronic disease is key to staying well. Managing these diseases can be tricky. Chronic myeloid leukemia (CML) is a great example.

You do what you can – what you’re told – to beat the cancer. Chemotherapy is recommended and it works. Years later, though, you’re diagnosed with a blood cancer that could be related to the chemotherapy. Is this really happening?

The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.

People diagnosed with chronic myeloid leukemia (CML) are living longer than ever before. A number of effective therapies are available for all phases of the disease, but living with CML has its challenges.

The cure rate for one type of blood cancer that affects children - acute lymphoblastic leukemia (ALL) – is now about 80 percent. For the remaining 20 percent of kids who develop the disease, the outlook can be dire.

Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.

If you focus on maintaining a healthy lifestyle, you’re less likely to get sick. That’s simple logic. Researchers now think this approach might be an effective way to treat cancer.